nifuratel has been researched along with Leishmaniasis, Visceral in 1 studies
*Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaña-Fouce, R; Galli, G; García-Estrada, C; Melcon-Fernandez, E; Pérez-Pertejo, Y; Reguera, RM | 1 |
1 other study(ies) available for nifuratel and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of
Topics: Animals; Antiprotozoal Agents; Female; Leishmania donovani; Leishmaniasis, Visceral; Mice; Nifuratel; Phosphorylcholine | 2023 |